Cory Jubinville, PhD
Stock Analyst at LifeSci Capital
(4.59)
# 961
Out of 5,081 analysts
141
Total ratings
50.7%
Success rate
19.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cory Jubinville, PhD
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Reiterated: Buy | $6 | $3.61 | +66.20% | 13 | Oct 5, 2026 | |
| TNYA Tenaya Therapeutics | Reiterated: Buy | $4 | $0.4086 | +878.95% | 33 | Aug 6, 2026 | |
| MREO Mereo BioPharma Group | Reiterated: Hold | n/a | $0.275 | - | 14 | Jan 12, 2026 | |
| SION Sionna Therapeutics | Initiated Coverage: Buy | $60 | $3.69 | +1,526.02% | 1 | Dec 23, 2025 | |
| IKT Inhibikase Therapeutics | Initiated Coverage: Buy | $5 | $1.52 | +228.95% | 1 | Dec 1, 2025 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $88 | $19.95 | +341.10% | 5 | Nov 18, 2025 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $9 | $2.28 | +294.74% | 17 | Nov 7, 2025 | |
| LRMR Larimar Therapeutics | Reiterated: Buy | $22 | $2.24 | +882.14% | 21 | Nov 5, 2025 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | $85 → $84 | $70.03 | +19.95% | 14 | Nov 5, 2025 | |
| LQDA Liquidia | Reiterated: Buy | $54 → $67 | $43.74 | +53.18% | 22 | Nov 3, 2025 |
Prime Medicine
Oct 5, 2026
Reiterated: Buy
Price Target: $6
Current: $3.61
Upside: +66.20%
Tenaya Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $4
Current: $0.4086
Upside: +878.95%
Mereo BioPharma Group
Jan 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.275
Upside: -
Sionna Therapeutics
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $60
Current: $3.69
Upside: +1,526.02%
Inhibikase Therapeutics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.52
Upside: +228.95%
Tectonic Therapeutic
Nov 18, 2025
Reiterated: Buy
Price Target: $88
Current: $19.95
Upside: +341.10%
Rocket Pharmaceuticals
Nov 7, 2025
Reiterated: Buy
Price Target: $9
Current: $2.28
Upside: +294.74%
Larimar Therapeutics
Nov 5, 2025
Reiterated: Buy
Price Target: $22
Current: $2.24
Upside: +882.14%
Tarsus Pharmaceuticals
Nov 5, 2025
Reiterated: Buy
Price Target: $85 → $84
Current: $70.03
Upside: +19.95%
Liquidia
Nov 3, 2025
Reiterated: Buy
Price Target: $54 → $67
Current: $43.74
Upside: +53.18%